Pharmacogenetics
Subtitle: opportunities and challenges for health innovation.
Contributors: Organisation for Economic Co-operation and Development. Secretary-General.; SourceOECD (Online service)
Series: OECD innovation strategy
Publisher: OECD
Published: 2009
Place of publication: Paris
Language: eng
Number of pages: 131
ISBN-13: 9789264076792; 9789264076808
Subjects: Pharmacogenetics; Pharmaceutical industry -- Technological innovations
Other titles: Opportunities and challenges for health innovation
Description: Pharmacogenetics helps us understand the relationship between an individual’s genetic make-up and the way medicines work for each person. This book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise the use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits. The book argues for large-scale studies to validate the biomarkers that underpin pharmacogenetics and policies to share the cost and risk of using  pharmacogenetics to improve the use of existing  medicines. Governments and others need to align regulatory, reimbursement and other incentives and work  with industry to measure better the impacts of pharmacogenetics. Health systems need to take positive steps to adapt to the use of pharmacogenetics and ensure that health professionals receive adequate training.
Notes: "This work is published on the responsibility of the Secretary-General of the OECD"--T.p. verso.

Corrigenda to OECD publications may be found online at: www.oecd.org/publishing/corrigenda.

OECD-code: 93 2009 08 1 P.

Includes bibliographical references.

Also available online.